PDS Biotechnology Corporation (PDSB) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
PDS Biotechnology Corporation (PDSB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $74.2M, listed on NASDAQ, employing roughly 24 people, carrying a beta of 1.50 to the broader market. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Led by Frank K. Bedu-Addo, public since 2015-09-30.
Snapshot as of May 15, 2026.
- Spot Price
- $1.35
- Total OI
- 9.7K